Related Experiment Video

Updated: Jun 6, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Surgical approach to end-stage heart failure

Stefan Klotz1, Hans H Scheld

  • 1Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster, Muenster, Germany. stefan.klotz@ukmuenster.de

Current Opinion in Anaesthesiology
|November 19, 2010
PubMed

Insights

Cardiac transplantation remains the gold standard for end-stage heart failure. Ventricular assist devices (VADs) offer increasing promise for patients ineligible for transplants, improving quality of life.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Technology

Background:

  • End-stage heart failure presents significant clinical challenges with increasing prevalence.
  • Declining heart transplant rates necessitate exploration of alternative organ-preserving therapies.

Purpose of the Study:

  • To review the potential challenges associated with surgical therapies for end-stage heart failure patients.
  • To evaluate current and emerging treatment modalities for advanced heart failure.

Main Methods:

  • Comprehensive literature review of surgical and device-based therapies for end-stage heart failure.
  • Analysis of outcomes, limitations, and future directions for cardiac transplantation, ventricular assist devices (VADs), and organ conservation surgeries.

Main Results:

  • Cardiac transplantation is the leading surgical treatment, but organ availability is a major limitation.
  • Ventricular assist device (VAD) therapy is expanding, with advancements in device design and implantation techniques enhancing outcomes and quality of life.
  • Organ conservation surgeries (e.g., CABG, ventricular restoration) have not met expectations in end-stage patients, though minimally invasive approaches may evolve.

Conclusions:

  • Cardiac transplantation offers superior outcomes for eligible end-stage heart failure patients.
  • Ventricular assist device (VAD) therapy is a growing alternative, particularly with the development of smaller, implantable devices for destination therapy.
  • Minimally invasive and transcatheter techniques may play a larger role in future heart failure management.
Abstract

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...